A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis
Status:
Recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
This is a clinical study in children and adolescents (5-17 years) with allergy to pollen from
birch (or related trees). It compares the tree SLIT-tablet with placebo in relieving
rhinoconjunctivitis symptoms during the birch/tree pollen season based on the average
allergic rhinoconjunctivitis daily total combined score.
The study will also collect health-related quality of life information in the groups treated
with the tree SLIT-tablet or with placebo during the pollen season.
The trial medication used is already approved to treat allergic rhinitis caused by birch/tree
pollen in adults in several countries?.